Clinical outcome and monitoring of minimal residual disease in patients with acute lymphoblastic leukemia expressing the MLL/ENL fusion gene

American Journal of Hematology

Volumn 86, Issue 12, 2011, Pages 993-997

  Elia, Loredana ^a   Grammatico, Sara ^a   Paoloni, Francesca ^b   Vignetti, Marco ^a   Rago, Angela ^a   Cenfra, Natalia ^a   Mecarocci, Sergio ^a   Mancini, Marco ^a   Luciani, Matteo ^c   Di Raimondo, Francesco ^d   Cazzaniga, Giovanni ^e   Matarazzo, Mabel ^a   Moleti, Maria Luisa ^a   Santoro, Lidia ^f   Gaidano, Gianluca ^g   Foà, Robin ^a   Mandelli, Franco ^b   Cimino, Giuseppe ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b GIMEMA Foundation   (Italy)

^c Hematology Unit   (Italy)

^d UNIVERSITY OF CATANIA   (Italy)

^e UNIVERSITY OF MILANO BICOCCA   (Italy)

^f S G MOSCATI HOSPITAL   (Italy)

^g UNIVERSITY OF EASTERN PIEDMONT   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CYTOGENETICS; FEMALE; FOLLOW UP; FUSION GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; INFANT; LEUKOCYTE COUNT; MALE; MINIMAL RESIDUAL DISEASE; OUTCOME ASSESSMENT; PATIENT MONITORING; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS;

ADOLESCENT; ADULT; AGE FACTORS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION REGULATION, LEUKEMIC; HUMANS; INFANT; MALE; MIDDLE AGED; MYELOID-LYMPHOID LEUKEMIA PROTEIN; NEOPLASM, RESIDUAL; ONCOGENE PROTEINS, FUSION; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROGNOSIS; REMISSION INDUCTION; ROME; SURVIVAL ANALYSIS; TRANSCRIPTIONAL ELONGATION FACTORS; YOUNG ADULT;

EID: 81355148755     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.22161     Document Type: Article

References (19)

1. Djabali M, Selleri L, Parry P, et al. A trithorax-like gene is interrupted by chromosome 11q23 translocations in acute leukaemias. Nat Gen 1992; 2: 113-118.
2. Gu Y, Nakamura T, Alder H, et al. The t(4;11) chromosome translocation of human acute leukemias fuses the ALL-1 gene, related to Drosophila trithorax, to the AF-4 gene. Cell 1992; 71: 701-708.
3. Tkachuk DC, Kohler S, Cleary ML. Involvement of a homolog of Drosophila trithorax by 11q23 chromosomal translocations in acute leukemias. Cell 1992; 71: 691-700.
4. Slany RK. The molecular biology of mixed lineage leukemia. Haematologica 2009; 94: 984-993.
5. Stam RW, Schneider P, Hagelstein JAP, et al. Gene expression profiling-based dissection of MLL translocated and MLL germline acute lymphoblastic leukemia in infants. Blood 2010; 115: 2835-2844.
6. Rubnitz JE, Camitta BM, Mahmoud H, et al. Childhood acute lymphoblastic leukemia with the MLL-ENL fusion and t(11;19)(q23;p13.3) translocation. J Clin Oncol 1999; 17: 191-196.
7. Pui CH, Gaynon PS, Boyett JM, et al. Outcome of treatment in childhood acute lymphoblastic leukaemia with rearrangements of the 11q23 chromosomal region. Lancet 2002; 359: 1909-1915.
8. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidium thiocyanatephenol-chloroform extraction. Anal Biochem 1987; 162: 156-159.
9. Pallisgaard N, Hokland P, Riishøj DC, et al. Multiplex reverse transcription-polymerase chain reaction for simultaneous screening of 29 translocations and chromosomal aberrations in acute leukemia. Blood 1998; 92: 574-588.
10. Elia L, Mancini M, Moleti L, et al. A multiplex reverse transcriptase-polymerase chain reaction strategy for the diagnostic molecular screening of chimeric genes: A clinical evaluation on 170 patients with acute lymphoblastic leukemia. Haematologica 2003; 88: 275-279.
11. Flohr T, Schrauder A, Cazzaniga G, et al. International BFM Study Group (I-BFM-SG) minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia. Leukemia 2008; 22: 771-782.
12. Van der Velden VHJ, Corral L, Valsecchi MGJansen MW, et al. Prognostic significance of minimal residual disease in infants with acute lymphoblastic leukemia treated within the Interfant-99 protocol. Leukemia 2009; 23: 1073-1079.
13. Cimino G, Elia L, Mancini M, et al. Clinico-biologic features and treatment out come of adult pro-B ALL patients enrolled in the GIMEMA 0496 study: Absence of the ALL1/AF4 and of the BCR-ABL fusion genes correlates with a significant better clinical outcome. Blood 2003; 102: 2014-2020.
14. Fu JF, Liang DR, Shih LY. Analysis of acute leukemias with MLL/ENL fusion transcripts. Identification of two novel breakpoints in ENL. Am J Clin Pathol 2007; 127: 24-30.
15. Miyamoto T, Nagafuji K, Akashi K, et al. Persistence of multipotent progenitors expressing AMLI/ETO transcripts in long-term remission patients with t(8;21) acute myelogenous leukemia. Blood 1996; 87: 4789-4796.
16. Burmeister T, Meyer C, Schwartz S, et al. The MLL recombinome of adult CD10-negative B-cell precursor acute lymphoblastic leukemia: Results from the GMALL study group. Blood 2009; 113: 4011-4015.
17. Cimino G, Cenfra N, Elia L, et al. The therapeutic response and clinical out come of adults with ALL1(MLL)/AF4 fusion positive acute lymphoblastic leukemia according to the GIMEMA experience. Haematologica 2010; 95: 837-840.
18. Elia L, Gottardi E, Floriddia G, et al. Retrospective comparison of qualitative and quantitative reverse transcriptase polymerase chain reaction in diagnosing and monitoring the ALL1-AF4 fusion transcript in patients with acute lymphoblastic leukemia. Leukemia 2004; 18: 1824-1830.
19. Miyamoto T, Weissman IL, Akashi K. AML1/ETO-expressing nonleukemic stem cells in acute myelogenous leukemia with 8;21 chromosomal trans location. PNAS 2000; 97: 7521-7526.